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Identification of a periodontal 
pathogen and bihormonal cells in 
pancreatic islets of humans and a 
mouse model of periodontitis
Vladimir Ilievski1, Peter T. Toth2,3, Klara Valyi-Nagy4, Tibor Valyi-Nagy4, Stefan J. Green5,6, 
Rosann S. Marattil7, Haider W. Aljewari8, Barton Wicksteed9, Neil M. O’Brien-Simpson10, 
Eric C. Reynolds10, Brian T. Layden9, Terry G. Unterman9,11 & Keiko Watanabe1 ✉
Results from epidemiological and prospective studies indicate a close association between periodontitis 
and diabetes. However the mechanisms by which periodontal pathogens influence the development 
of prediabetes/diabetes are not clear. We previously reported that oral administration of a periodontal 
pathogen, Porphyromonas gingivalis (Pg) to WT mice results in insulin resistance, hyperinsulinemia, and 
glucose intolerance and that Pg translocates to the pancreas. In the current study, we determined the 
specific localization of Pg in relation to mouse and human pancreatic α- and β-cells using 3-D confocal 
and immunofluorescence microscopy and orthogonal analyses. Pg/gingipain is intra- or peri-nuclearly 
localized primarily in β-cells in experimental mice and also in human post-mortem pancreatic samples. 
We also identified bihormonal cells in experimental mice as well as human pancreatic samples. A low 
percentage of bihormonal cells has intracellular Pg in both humans and experimental mice. Our data 
show that the number of Pg translocated to the pancreas correlates with the number of bihormonal cells 
in both mice and humans. Our findings suggest that Pg/gingipain translocates to pancreas, particularly 
β-cells in both humans and mice, and this is strongly associated with emergence of bihormonal cells.
Periodontitis is a disease characterized by destruction of gingiva and tooth-supporting bone by a host immuno-
logical response triggered by periodontal pathogens. Thus, the primary etiological factor of periodontitis is bacte-
ria. Interestingly, certain periodontal pathogens are detected in different organs such as the liver1, aorta2, arteries3,4 
and the brain5, but the effects of periodontal pathogens in these tissues and organs are poorly understood.
One of the major periodontal pathogens, Porphyromonas gingivalis (Pg), is a non-motile gram-negative obli-
gate anaerobic bacteria that possesses virulence factors including cysteine proteases referred to as gingipains 
(arginine specific gingipain, RgpA/B and lysine specific gingipain, Kgp) which are associated with the outer cell 
membrane and membrane vesicles6. It has been reported that a heterodimer of gingipains, HRgp, has the ability 
to enter the nucleus of epithelial cells in vitro7, but its function in the nucleus is not known. We have recently 
shown that Pg orally administered to mice is translocated to the brain and is localized peri- and intra-nuclearly in 
neurons, astrocytes and microglial cells in the hippocampus and this is associated with the development of senile 
plaques5. This suggests that Pg/gingipain is able to invade cells in distant organs and may result in a pathological 
conditions. In regards to a relationship between periodontal pathogens and the human pancreas, the presence of 
a periodontal pathogen, Fusobacterium species was reported in human pancreatic ductal adenocarcinomas and 
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cyctic fluid from Intraductal papillary mucinous neoplasm8,9. Although the presence of Pg in the pancreas has not 
been investigated, increased antibody to Pg has been detected in the plasma of subjects with pancreatic cancer10.
We have recently determined that mice orally administered Pg develop insulin resistance and hyperinsuline-
mia while maintaining normal glucose levels indicating a prediabetic condition11 and that Pg translocates to the 
pancreas12. These results suggest that Pg may influence β-cell function. To gain understanding of how Pg interacts 
with islet cells, we set out to determine the specific localization of Pg in α- and β-cells in mouse pancreatic islets 
and human pancreatic islet cells. In this process we quantitated the relative number of α- and β-cells containing 
Pg and the emergence of bihormonal cells which express both insulin and glucagon in response to translocated 
Pg.
The emergence of bihormonal cells in animal models has been reported following near complete destruc-
tion of β-cells (99% ablation) by chemical agent13 or by forced expression/deletion of β- or α-cell specific tran-
scription factors14–17 using conditional knockout and/or lineage tracing mice. Re-differentiation of α-cells from 
de-differentiated β-cells18 also represents another means of developing intermediate/bihormonal cells. Beta- to 
α-cell conversion has also been reported as a result of DNMT1 deletion19. Taken together, these studies show 
plasticity of pancreatic islet cells under defined conditions. Most recently, emergence of bihormonal cells was 
observed in a mouse model of experimental autoimmune diabetes20. In contrast to animal studies, quantita-
tive data on human pancreatic bihormonal cells are scarce21,22. A recent study using human pancreatic samples 
obtained following pancreatoduodenectomy reported the higher percentage of bihormonal cells in an insulin 
resistant group compared with an insulin sensitive group, suggesting a possible adaptive response to insulin 
resistance23.
Here we show that orally applied Pg in mice translocates to and resides in intra- and peri-nuclear locations 
primarily in islet β-cells. The emergence of bihormonal cells was strongly associated with the presence of Pg/
gingipain in pancreatic islets of these animals as well as in human post-mortem pancreatic samples. These obser-
vations support the novel concept that oral bacteria causing periodontal infection can translocate to pancreatic 
islets where they may impact islet pathophysiology and the development of bihormonal cells.
Results
Pg/gingipain translocates to nuclear- and peri-nuclear regions of β-cells but not to α-cells in 
animals administered Pg. Following oral application of Pg 3 times per week for 22 weeks to simulate 
chronic periodontitis, the presence of Pg/gingipain was determined. Pg/gingipain was identified in pancreata of 
all mice that were administered Pg (N = 9) but none in control mice treated with vehicle alone (N = 10) by immu-
nofluorescence (IF) microscopy and qPCR (N = 3/group) (Fig. 1A,B). 3-D confocal microscopy and orthogonal 
analyses revealed nuclear- or peri-nuclear localization of Pg/gingipain in β-cells (Fig. 1C,D, respectively).
Interestingly, Pg/gingipain was localized intracellularly in β-cells but not in α-cells that were identified based 
on insulin and glucagon staining, respectively (p < 0.001) (Fig. 2A,B). Again, no Pg/gingipain was detected in 
pancreatic samples from control animals.
In the experimental group, 17.7% (S.D. ± 7.3%) of glucagon+ cells expressed both glucagon and insulin 
(Fig. 3A,B) whereas significantly fewer (mean 1.3%) glucagon+ cells expressed both insulin and glucagon in con-
trol group (p < 0.01) (Fig. 3B). These bihormonal cells were confirmed by 3-D and orthogonal analysis (Fig. 3C,D, 
respectively). A low percentage of bihormonal cells contain Pg/gingipain (Fig. 3E,F).
Bihormonal cells express the β-cell transcription factor Nkx6.1. Nkx6.1 is a transcription factor 
that is expressed in islet β-cells to repress expression of the α-cell transcription factor, Arx, and is not expressed 
in mature α-cells. To confirm that bihormonal cells exhibit a characteristic of β-cells, we stained for expression 
of the β-cell specific transcription factor Nkx6.1. IF microscopy revealed that bihormonal cells that were positive 
for both insulin and glucagon co-expressed Nkx6.1 (Fig. 4A,D). 3-D and orthogonal analysis of bihormonal cells 
showed the intra-nuclear localization of Nkx6.1 (Fig. 4B,C respectively).
Pg/gingipain is identified in human pancreata of both diabetic and non-diabetic subjects. We 
obtained a total of 45 postmortem human pancreata samples of which 32 were FFPE (19 Non-DM, 13 DM) and 
13 frozen (11 Non-DM, 2 DM). Thus, of these 45 samples, 30 were from non-diabetic (Non-DM) and 15 from 
diabetic (DM) subjects (Table 1). In Non-DM subjects, 23% had Pg in the pancreas (Pg positive) and 77% were Pg 
negative (Table 1). In DM subjects, 40% were Pg positive and 60% Pg negative (Table 1). The Chi-square analysis 
reveals a Chi-square value of 5.662 with 1 degree of freedom. The two-tailed P value equals 0.01. Thus, the pro-
portion of subjects with Pg was significantly higher in DM compared to Non-DM groups.
Overall Pg/gingipain was identified by immunofluorescence microscopy or by qPCR in 13 of 45 (29%) of 
human pancreata.
Pg/gingipains are more strongly associated with β-cells than α-cells in human pancreata. 2-D 
IF microscopy and 3-D confocal microscopy analysis of human pancreatic tissue sections show the presence of 
peri- and intra-nuclear Pg/gingipain in β-cells (Fig. 5A,C). As was observed in mouse islets, the presence of intra- 
and peri-nuclear localization was confirmed by orthogonal analysis (Fig. 5D). Of 13 frozen samples for which we 
performed qPCR analysis for Pg positivity, 4 were positive for Pg and 9 were negative. The copy number of the Pg 
16S rRNA gene varied from 2.6 × 104 to 8.8 × 106 (mean 2.8 × 106) (Fig. 5B).
We had determined that Pg/gingipain signal was exclusively localized to β-cells in samples from mice (Fig. 2) 
and addressed this same question in samples from humans. In contrast to what we found in mice, Pg/gingipain 
was mainly localized to β-cells but was also present in α-cells (Fig. 6A,B) in human islets. The mean percent-
age of Pg positive β- and α-cells was 30% and 7.5% respectively and this difference was statistically significant 
(p < 0.001) (Fig. 6B).
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Figure 1. Pg/gingipain translocates to the pancreas and is present in β-cells. (A) Representative result using IF 
microscopy showing Pg/gingipain in pancreatic islets in experimental but not control animals. White arrows 
point to Pg/gingipain. Scale bar represents 60μm. N = 9 mice/experimental group and N = 10 mice/control 
group. (B) Results from qPCR for Pg 16 S rRNA genes performed on formalin fixed paraffin embedded (FFPE) 
sections (5/animal) show that Pg is present in islets from experimental animals but not controls. N = 3 mice/
group. The difference between groups is statistically significant (p** < 0.01). (C) Representative 3-D image 
from confocal microscopy of mouse pancreatic islet showing that Pg is localized in β-cells. (D) Orthogonal 
analysis of image confirming intra-nuclear localization of Pg in β-cells. a & b are orthogonal projections 
showing the side views of the main image cut through along vertical (red) and horizontal (green) lines. Green: 
insulin, Red: Pg, Blue: nuclei.
Figure 2. Pg is localized in β- but not in α-cells in experimental animals. (A) Representative image from IF 
microscopy and higher magnification of insets showing Pg, glucagon, and nuclear stain (top panels) and Pg, 
insulin and nuclear staining (bottom panels). Yellow: glucagon, Green: insulin, Red: Pg, Blue: nuclei. White 
arrows point to Pg in low magnification image. Scale bar represents 50μm. For separate channel images of 
40×, see Fig. S1. (B) Results from counting cells positive for Pg/gingipain. The total number of insulin+ cells 
and insulin+/Pg+ cells were counted per islet and the percentage of insulin+ cells that were positive for 
Pg were calculated (5 islets /mouse, N = 5 mice/group). Data show mean + S.D. There were no glucagon+ 
cells containing Pg. The difference in the percentage of α- vs. β-cells containing Pg is statistically significant 
(***p < 0.001).
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Figure 3. Bihormonal cells are evident in islets of the experimental mouse group. A low % of bihormonal cells 
contain Pg. (A) Upper panel is a representative islet from a control animal which does not exhibit bihormonal 
cells. Lower panel shows an islet from the experimental group. Emergence of bihormonal cells is evident (white 
arrows) in experimental animals as shown in a representative islets in bottom panel A. Yellow: glucagon, Green: 
insulin, Blue: nuclei. Representative of N = 7 animals/group. Scale bar represents 25μm. For separate channel 
images of 40×, see Fig. S2. (B) Percentage bihormonal cells in islets from control and experimental animals 
was calculated by identifying glucagon+/insulin+ cells divided by total number of glucagon+ cells per islet. 
4–5 islets/animal. N = 7 animals/group. Y-axis: % bihormonal cells, X-axis: C represents control group and E 
represents experimental group. Data are presented as mean + S.D. **p < 0.01. (C,D) Representative 3-D image 
from confocal microscopy and orthogonal images respectively showing the presence of bihormonal cells in an 
islet from an experimental mouse. a & b are orthogonal projections showing the side views of the main image 
cut through along vertical (red) and horizontal (green) lines. (E) Pg presence is shown in a bihormonal cell of 
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Bihormonal cells are more abundant in pancreata of DM subjects. Bihormonal cells were detected 
in human post-mortem pancreata from Non-DM (Fig. 7A) and DM subjects (Fig. 7B). The percentage of bihor-
monal cells was significantly higher in DM (17 ± 7.6%) compared with Non-DM subjects (9 ± 7.2%) (p < 0.001) 
(Fig. 7C). 2-D IF images (Fig. 7A,B) as well as 3-D and orthogonal analysis (Fig. 7D,E, respectively) show the 
presence of bihormonal cells. IF microscopy data indicate that Pg/gingipain is present in β-cells and in a low 
percentage of α-cells as well as bihormonal cells (Fig. 7F,G).
Bihormonal cells in human pancreata express the Nkx6.1 transcription factor. 2-D, 3-D and 
orthogonal analysis show β-cell transcription factor Nkx6.1 expression in the nucleus of bihormonal cells in 
human pancreata (Fig. 8A–E). The mean percentages of cells positive for Nkx6.1 were 0% for α-cells, 86% for 
β-cells and 34% for bihormonal cells (Fig. 8F).
A strong correlation exists between Pg invasion and the emergence of bihormonal cells in both 
human and mice. We next determined the relationship between the number of bihormonal cells and the 
presence or absence of Pg in the pancreas in both humans and mice (Fig. 9A,B). In both humans and mice, the 
number of bihormonal cells was significantly higher in Pg+ compared with Pg- samples (p < 0.0001).
A correlation analysis was performed to determine if there is a relationship between the number of Pg and 
the number of bihormonal cells. This analysis showed a strong correlation between these two variables in both 
mice and human samples (correlation coefficient r = 0.821, p < 0.0001 for humans; r = 0.853, p < 0.0001 for mice) 
(Fig. 9C,D).
Mice receiving oral application of Pg develop glucose intolerance, insulin resistance, hyperinsu-
linemia while maintaining normal glycemic levels. Oral application of Pg 3 times per week (Mondays, 
Wednesdays, Fridays) for 22 weeks in mice resulted in glucose intolerance (Fig. 10A), insulin resistance (Fig. 10B) 
and hyperinsulinemia (Fig. 10C) indicating increased β-cell release of insulin to maintain the normal glucose 
levels (Fig. 10D)11.
Discussion
Nearly 50% of human adults in the U.S. have periodontitis24 with 20% having moderate, and 10% severe perio-
dontitis. Periodontitis is a disease characterized by destruction of gingiva and tooth-supporting bone by a host 
immunological response to periodontal pathogens. It is reported that periodontal bacteria (gram-negative bac-
teria) are translocated to the liver1, aorta2, and arteries3,4 via the systemic circulation25–27 or possibly via the gut 
axis1, but the effects of periodontal pathogens in these tissues are poorly understood. We have recently reported 
the presence of Pg/gingipain in the brain (hippocampus) of young wild type mice that were administered Pg 
orally 3 times per week for 22 weeks and these mice developed neuropathology consistent with that of Alzheimer’s 
disease5. Our current study is the first to show the intra-cellular, peri-nuclear and intra-nuclear localization of a 
periodontal pathogen/product in pancreatic β-cells in mice as a result of oral application of Pg as well as in human 
pancreatic β-cells in both non-diabetic and diabetic subjects. Interestingly, the presence of Pg/gingipain in 29% of 
the randomly selected human pancreata used in this study corresponds to the percentage of humans with mod-
erate to severe periodontitis. Unfortunately, in our current study, data regarding the periodontal condition were 
not available from these subjects. Nonetheless, given that the primary niche of Pg is the oral cavity, Pg/gingipain 
identified in the human pancreas most likely originated from this site.
In humans, the presence of Pg in the oral cavity or increased level of serum antibody to Pg is associated with 
pancreatic cancer10 but the actual presence of Pg in pancreatic cancer tissues has not been reported. However, 
a periodontal pathogen Fusobacterium sp. has been detected in pancreatic ductal adenocarcinomas and in pan-
creatic cystic neoplasm cyst fluid8,9. The result of our analysis of human post-mortem pancreatic samples is the 
first to show the presence of a periodontal pathogen in non-cancerous subjects, and specifically in human islets.
We used both a mouse monoclonal antibody (61BG1.3) which is specific to an epitope in the beta-adhesin 
domain of gingipains (G907-T931) and a rabbit polyclonal antibody raised against the active site of His sequence 
of gingipain28 to confirm the presence of Pg/gingpains in islets. Although positive signals using these antibodies 
reflect the presence of gingipains, this does not preclude the presence of whole bacteria residing peri-nuclearly or 
intra-nuclearly in β-cells. Gingipains are part of the outer cell membrane or reside inside membrane vesicles and 
thus it is possible that our staining detects whole Pg, a fragment of Pg cell membrane and/or secreted gingipains. 
Pg is a non-motile, coccobacillus gram-negative obligate anaerobe with an approximate size of 1.2 μm × 0.5 μm 
with an outer membrane vesicle of approximately 40 nm29. Since the size of a human β-cell is approximately 10–12 
μm with a nuclear diameter of 6.0–8.0 μm30–32, our antibodies may detected whole Pg. In support of this, we 
detected Pg specific 16S rRNA genes in both mouse and human islets. However, we are not certain if this reflects 
the presence of either actively dividing or dormant bacteria.
Identification of a periodontal pathogen or its product in the nucleus of pancreatic islet cells is surprising. 
However, Pg is known to invade host cells such as epithelial7 and endothelial cells in vitro33. Further, a heterodi-
mer derived from gingipain RgpA designated as HRgpA is known to enter the nucleus of epithelial cells and local-
ize in and around the nucleus of these cells in vitro7. We recently reported the peri- and intra-nuclear localization 
an experimental mouse. Yellow: glucagon, Green: insulin, Red: Pg, Blue: nucleus. Scale bar represents 10 μm. 
(F) Percentage of Pg positive α-, β- and bihormonal cells. Y-axis: % cells positive for Pg, X-axis: cell types. 449 
α-cells, 968 β-cells and 72 bihormonal cells were counted. N = 5 experimental mice. Data are presented as mean 
+ S.D. ***p < 0.001.
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of Pg/gingipain in neurons, microglial cells and astrocytes in the brain (hippocampus) of mice orally adminis-
tered Pg5.
A number of bacteria and their products are known to enter and reside in host cell cytoplasm or the 
nucleus34,35. These bacteria include E. coli36,37, Legionella penumophila38 and its product OrfX which specifically 
targets the nucleus39, and Rickttsia richettsii which can invade the nucleus and form endonuclear colonies in 
human cells40,41. The mechanism that facilitates entry of bacteria or its product, referred to as “nuclear modulin 
(nucleomodulin),” into the nucleus is not clear as nucleomodulins usually lack a classical nuclear localization 
Figure 4. Bihormonal cells from both control and experimental groups express the β-cell transcription factor, 
Nkx6.1. (A) Upper panels are from control and lower panels are images from experimental groups. Nkx6.1 
is expressed in bihormonal cells in experimental and control mice (N = 7). Scale bar represents 25μm. For 
separate channel images of 40×, see Fig. S3. (B) 3-D image from confocal microscopy of experimental mouse 
pancreatic islet cells stained for glucagon, insulin, Nkx6.1 and nuclei. Nkx6.1 is evident in the nucleus of a 
bihormonal cell. (C) Orthogonal analysis of a representative bihormonal cell expressing nuclear Nkx6.1. Each 
image corresponds to an image shown in (B). a & b are orthogonal projections showing the side views of the 
main image cut through along vertical (red) and horizontal (green) lines. Yellow: glucagon, Red: insulin, Green: 
Nkx6.1, Blue: nuclei. (D) % of cells positive for Nkx6.1. A total of 62 α-cells, 104 β-cells, and 15 bihormonal cells 
were counted. N = 4 experimental mice. Data show mean + S.D. *p < 0.05, ****p < 0.0001.
Non-DM 
(N = 30) DM (N = 15) Total (N = 45)
Pg+ Pg- Pg+ Pg− Pg+ Pg−
# of subjects 7 23 6 9 13 32
% Pg+ 23% 77% 40% 60% 29% 71%
Table 1. Distribution of Pg+ and Pg− subjects grouped by Non-DM and DM status. Results from detection of 
Pg by IF microscopy (N = 32) and qPCR (N = 13). Chi-square analysis.
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sequence (NLS)42. Pg/gingipains also do not have canonical NLS7. Study of the mechanism by which Pg and/or 
gingipain gains access to the nucleus primarily in β-cells may give us insight into the development of prediabetes 
and diabetes associated with oral bacteria. It is not clear why Pg/gingipain specifically invades β-cells in mice and 
significantly more in β- than α-cells in humans.
Bihormonal cells are considered an intermediate stage in α- to β-cell transdifferentiation16 and may be impor-
tant as a β-cell compensatory response to IR22,43. Thus, the emergence of bihormonal cells is potentially a phys-
iologically important mechanism to cope with IR and/or loss of functional β-cells. IF and confocal microscopy 
with orthogonal analysis showed nuclear localization of Nkx6.1 in a low percentage of bihormonal cells in both 
human and experimental mice. Nkx6.1 is a transcription factor specific to β-cells within the islets, which binds 
and inhibits transcription of the α-cell specific Arx gene thereby repressing α-cell identity44. However, secretion 
of insulin from bihormonal cells isolated from mice subjected to oral application of Pg has yet to be confirmed 
by functional analysis.
The literature reporting quantitative data on human bihormonal cells is limited21,22, and previous studies have 
not considered the possibility that bacterial pathogens may contribute to their emergence. Two possible means to 
induce conversion of α-cell to β-cell or β-cell to α-cell have been identified: (1) near complete ablation of β-cells 
using chemical agents13,45,46 and (2) forced expression/deletion of β- or α-cell specific transcription factors and/
or deletion of Dnmt1 or FOXO1 transcription factor in β-cells in mice14–16,18,19. We found that Pg/gingipain is 
not detected in mouse α-cells and at a low % in human α-cells, making it unlikely that Pg directly induces α- to 
Figure 5. Human pancreatic islets are positive for Pg/gingipain. (A) 9 out of 32 FFPE samples from human 
subjects (age >50 y) show the presence of Pg/gingipain in islets. Representative IF images. Scale bar represents 
60μm. (B) 4 out of 13 frozen samples were positive for Pg 16S rRNA genes detected by qPCR. Y-axis: copies/5 
FFPE slides. ***p < 0.001. (C) 3-D image from confocal microscopy of human pancreatic islet composed from 
Z-sections, showing Pg/gingipain (red) associated with β-cells. Scale bar represents 5 μm. (D) Orthogonal 
analysis of a β-cell confirming intra-nuclear localization of Pg/gingipain. a & b represent orthogonal 
projections. Red: Pg, Green: insulin, Blue: nuclei.
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β-cell transdifferentiation. However, whether the emergence of bihormonal cells is based on α- to β-cell transdif-
ferentiation or β-cell de-differentiation/conversion in the context of an oral bacteria reaching the pancreas will 
require additional studies as some of our bihormonal cells in mice and human did contain Pg/gingipain. Thus, 
the study using lineage tracing methods would be necessary to identify the direction or bi-direction of islet cell 
transdifferentiation and/or dedifferentiation. In our mouse model of experimental periodontitis the percentage 
of β-cell destruction/apoptosis was a mean of 8%12 and yet bihormonal cells (mean 17.7% of total count of gluca-
gon+ cells) emerged, suggesting that near complete destruction of β-cells may not be necessary for the emergence 
of bihormonal cells in our model system. Interestingly, Pg-LPS has been shown to impact gene expression by 
significantly reducing DNA methyltransferase (DNMT1) expression47. Inactivation of both Dnmt1 and Arx in 
adult mice has been shown to drive transdifferentiation/conversion of α- to β-cells16. It has also been shown that 
β-cells deficient in DNMT1 are converted to α-cells19. Thus, Pg with cell membrane associated LPS present in the 
nucleus of β-cells may be altering the methylation signature and thus β- and α-cell identity. Further, intra-cellular 
localization of Pg/gingipain suggests other epigenetic functions of Pg/product. For example, it is reported that Pg 
decreases trimethylation of histone H3K448. Furthermore, treatment of cultured pancreatic islets with a histone 
methyltransferase inhibitor results in colocalization of both glucagon and insulin in mouse islets, i.e. bihormonal 
cells49. Based on these data, it is possible that Pg translocation from the oral cavity to the nuclei of islet cells may 
lead to the decreased trimethylation of H3K4 and thereby contribute to the emergence or maintenance of bihor-
monal cells. In summary, we present data obtained by IF, confocal microscopy and qPCR that Pg is present in 
human pancreata and is at a higher incidence in the pancreata of DM than Non-DM humans.
This is the first study to investigate the presence and intra-cellular localization of a periodontal pathogen and/
or its product in human pancreata and also in the pancreas of an animal model of experimental periodontitis. 
Our data indicate that Pg/gingipain is translocated from the oral cavity to pancreatic islets and localized primarily 
in β-cells in both humans and mice. In this process, emergence of bihormonal cells occurs. The results from a 
recent study show that Pg expresses dipeptidyl peptidase 4 (DPP4) which degrades incretins and thus reduces 
insulin levels which is accompanied by a substantially elevated glucose levels at a 15 min time point following oral 
glucose administration50. PgDPP4 does not appear to account for our results since our experimental mice show 
high insulin levels and normal glycemic levels, thus suggesting that non-DPP4 factors/effects may be involved. 
However, we can’t exclude the possibility that PgDPP4 may be present but not contributing to net effects on insu-
lin levels. Finally, based on the published literature on nuclear invasion of bacteria/products in various cell types, 
it is interesting to speculate that Pg/gingipains may epigenetically influence development of bihormonal cells.
Methods
Animals. This study was carried out in strict accordance with the recommendations outlined in the Guide 
for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by 
the Institutional Animal Care and Use Committee at the University of Illinois at Chicago (Protocol approval 
#15–142). Twenty 8-week old male C57BL/6 mice were used for this study. Oral application of Pg was performed 
3 times per week for 22 weeks. At baseline and at week 22, a glucose tolerance test was performed by intraperito-
neal injection of 50% dextrose solution (2 g/kg body weight) and glucose levels in tail blood were determined at 
15, 30, 60, 90 and 120 min post-dextrose injection using a glucometer. Fasting insulin levels were determined by 
ELISA (10-1247-01, Mercodia AB, Uppsala, Sweden) and insulin resistance was calculated using the homeostasis 
model assessment (HOMA-IR)51.
Figure 6. Pg/gingipain is localized more in β-cells compared with α-cells in human pancreata. (A) 
Representative IF image of human pancreata that are positive for Pg/gingipain. α-cells (yellow) do not have 
peri-nuclear or intra-nuclear Pg/gingipain but peri-nuclear Pg/gingipain is evident in β-cells (green). White 
arrows point to Pg. Yellow: glucagon, Green: insulin; Red: Pg, Blue: nuclei. Scale bar represents 25μm. (B) 
Percentage of α- and β-cells positive for Pg/gingipain. X-axis: α-cells and β-cells, Y-axis: percentage of α- or 
β-cells positive for Pg/gingipain. Cells were counted in 4 rectangular areas of 400μm X 300μm per sample in 
samples from 5 human subjects that were positive for Pg in islets. Total of 274 α-cells and 197 β-cells were 
counted. Data show mean ± S.D. ***p < 0.001.
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Human pancreata. A total of 45 human post-mortem pancreata samples (age >50) were obtained from the 
Department of Pathology at the University of Illinois at Chicago. Of these 45 samples, 32 were paraffin embedded 
and 13 were from frozen tissue samples. The identity of subjects were de-identified and only the age, the diagnosis 
or absence of diabetes, types of diabetes and cause of death were provided. Exclusion criterion was subjects with 
diagnosis of pancreatic or any other cancer. The use of human post-mortem pancreatic tissues was approved 
by the Institutional Review Board at the University of Illinois at Chicago (Protocol approval # 2018-0759). 
Figure 7. Bihormonal cells are detected in human pancreata from Non-DM and DM subjects. Pg is present 
in β-cells and in a low % of α-cells as well as bihormonal cells. (A) Representative result from IF microscopy 
showing the presence of bihormonal cells in human (Non-DM) post-mortem samples. White arrows indicate 
bihormonal cells. Scale bar represents 25 μm. Insets show glucagon+, insulin+, DAPI stained and merged 
images. Yellow: glucagon, Green: insulin, Blue: nuclei. Representative of N = 13 Non-DM samples. For separate 
channel images of 40×, see Fig. S4. (B) Bihormonal cells detected in pancreata of human DM subjects. White 
arrows point to bihormonal cells. Insets show glucagon+, insulin+, DAPI stained and merged images. 
Red: glucagon, Green: insulin, Blue: nuclei. Representative of N = 12. Scale bar represents 25 μm. (C) The 
percentage of bihormonal cells is significantly higher in DM compared with Non-DM subjects (***p < 0.001). 
% bihormonal cells was determined by counting the number of cells positive for insulin and glucagon divided 
by the number of cells positive for glucagon. A total of 429 and 469 α-cells were counted in Non-DM and DM 
subjects respectively. Two fields of 400 × 300 μm rectangle area were counted per subject. Data show means ± 
S.D. (D) 3-D images from confocal microscopy of glucagon+, insulin+ bihormonal cells (white arrows). Scale 
bar represents 5 μm. (E) Orthogonal analysis of bihormonal cell shown in (D). a & b represent orthogonal 
projections. Yellow: glucagon, Green: insulin, Blue: nuclei. (F) Representative image of bihormonal cells positive 
for Pg/gingipain. Yellow: glucagon, Green: insulin, Red: Pg/gingipain, Blue: nuclei. (G) Percentage of Pg positive 
α-, β- and bihormonal cells. Y-axis: % cells positive for Pg, X-axis: cell types. 347 α-cells, 444 β-cells and 51 
bihormonal cells were counted. N = 5 DM subjects. Data are presented as mean + S.D. ***p < 0.001.
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Appropriate informed consent was obtained from next of kin for autopsies and all methods were carried out in 
accordance with University of Illinois Hospital Institutional guidelines and regulations involving dead bodies.
Bacterial culture and oral application of Pg. Briefly, Pg (strain W83) was grown anaerobically as 
described in our previous study11. Cell density was determined by spectrophotometry at an optical density of 
550 nm based on a standard curve established using colony forming units (CFU). 1 × 109 Pg were transferred to 
microfuge tubes, vortexed briefly and centrifuged at 10,000 g for 2 min at 4 °C. Supernatants were discarded and 
the pellets were re-suspended in 4 oC PBS, and then re-pelleted by centrifugation. Supernatants were removed, 
and bacteria re-suspended in 100 μl of 2% carboxymethyl cellulose (CMC) in PBS and tubes immediately placed 
on ice until administered to mice. 100 μl of Pg in CMC containing 109 Pg (experimental group) or CMC alone 
(vehicle alone control group) was placed (2 applications of 50 μl) in the oral cavity every other day (Monday, 
Wednesday, and Friday) for 22 weeks. Animals were sacrificed using isoflurane anesthesia followed by cervical 
dislocation following 22 weeks of Pg application and pancreata were removed and fixed in paraformaldehyde to 
be embedded in paraffin.
Mouse pancreata. Mouse pancreata samples were obtained from C57BL/6 WT mice that received Pg orally 
(experimental animals, N = 10) or vehicle alone (control animals N = 10)11. Pancreata from these animals were 
harvested, fixed in formalin and embedded in paraffin (FFPE).
Immunofluorescence, confocal microscopy, and orthogonal analysis of human and mouse 
pancreas. Immunofluorescence microscopy (IF) was performed to detect Pg/gingipain and α- and β-cells. 
Briefly, 5μm thick sections were first de-paraffinized with xylene and rehydrated through a series of decreasing 
percentages of ethanol. Antigen retrieval was performed by microwaving sections in 1 mM ethylenediamine-
tetraacetic acid (EDTA), pH 8.0 or in 10 mM citrate buffer pH 6.0 for 5 min repeated 4 times. Cell and nuclear 
membrane permeabilization was performed by incubating sections in 0.25% Tween 20 in PBS for 30 min. To 
detect Pg/gingipain, tissue sections were incubated overnight at 4 oC either with mouse anti-Pg monoclonal 
antibody (DSHB, Iowa City, Iowa) or rabbit anti-Pg polyclonal antibody as primary antibody28 at a dilution of 
Figure 8. Human pancreatic bihormonal cells express Nkx6.1. (A) Representative images of bihormonal cells 
in DM subject expressing Nkx6.1 detected by IF microscopy. Scale bar represents 10 μm. For separate channel 
images of 40×, see Fig. S5. (B) 3-D image from confocal microscopy of a bihormonal cell expressing Nkx6.1. 
Scale bar represents 5 μm. (C) Orthogonal analysis of bihormonal cell staining for glucagon, Nkx6.1 and DAPI, 
(D) for insulin, Nkx6.1 and DAPI, and (E) for glucagon, insulin, Nkx6.1 and DAPI. a & b represent orthogonal 
projections. Yellow: glucagon, Red: insulin, Green: Nkx6.1, Blue: nuclei. (F) % of cells positive for Nkx6.1. 
A total of 76 α-, 118 β- and 30 bihormonal cells were counted. N = 4 DM subjects. Data show mean ± S.D. 
*p < 0.05, ****p < 0.0001.
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1:100, followed by donkey anti-mouse conjugated to Alexa Fluor 647 (A31571, Invitrogen, Grand Island, NY) or 
donkey anti-rabbit IgG conjugated to Alexa Fluor 594 (A21206, Invitrogen, Grand Island, NY) respectively as 
secondary antibody at room temperature for 1 hr. To detect β-cells, tissue sections were incubated overnight at 
4 °C with goat anti-insulin antibody (sc-7838, Santa Cruz Biotechnology, Inc., Dallas, TX) at a concentration of 
1:100, followed by donkey anti-goat IgG conjugated to Alexa Fluor 488 (A11055, Invitrogen, Grand Island, NY), 
as secondary antibody at room temperature for 1 hr. To detect α-cells, tissue sections were incubated overnight 
at 4 oC with anti-glucagon antibody at a concentration of 1:100 (ABCAM, Cambridge, MA), followed by donkey 
anti-mouse IgG conjugated to Alexa Fluor647 (A31571, Invitrogen, Grand Island, NY) as secondary antibody. 
To detect the β-cell specific transcription factor Nkx6.1, goat anti-Nkx6.1 antibody (AF5857, R&D Systems, Inc, 
Minneapolis, MN USA) was used as primary antibody at a concentration of 1:100. Sections were incubated for 
1.5 hr in a humidified chamber at room temperature, followed by anti-goat IgG conjugated with Alexa Fluor 488 
at a 1:800 dilution as secondary antibody. Isotypic controls were used to determine non-specific binding of anti-
bodies for all experiments. Nuclei were identified using DAPI as described12. For 3-D image reconstruction, an 
isovoxel data-set was acquired. Orthogonal analysis were performed based on compiled z-sections (0.08μm step 
size) obtained by confocal microscopy using the Imaris software (Bitplane, Inc) version 7.7.2.
For samples from mice, the percentage of cells that exhibited perinuclear/intranuclear Pg/gingipain in α- and 
β-cells was calculated under 40X magnification by counting the number of insulin+/Pg+ cells divided by the 
total number of insulin+ cells per islet or glucagon+/Pg+ cells divided by the total number of glucagon+ cells. 
A total of 5 islets per mouse were examined in 5 mice/group.
In human post-mortem pancreatic samples, the percentage of α- and β-cells exhibiting Pg+ was calculated as 
for mouse samples except that cells were counted in four rectangular areas of 400 × 300 μm per sample.
The percentage of bihormonal cells in mice were counted under 40X magnification by identifying glucagon+/
insulin+ cells relative to the total number of glucagon+ cells per islet. 4–5 islets/animal were examined in 7 
animals/group.
For human samples, the percentage of bihormonal cells positive for Pg/gingipain was determined by counting 
the number of cells identified by immunofluoresnce microscopy that were positive for both insulin and glucagon 
staining relative to the number of cells that stained positive for glucagon in a 400 × 300 μm rectangle under 40 X 
magnification.
Figure 9. The number of bihormonal cells is significantly higher in pancreatic samples that contain Pg in 
both humans and mice. A strong correlation exists between the number of Pg/gingipain and emergence of 
bihormonal cells in both humans and mice. (A,B) Scatter plots showing the number of bihormonal cells/field 
(400 × 300 μm) in Pg− and Pg+ samples in human post-mortem samples and mice pancreatic islets. Total of 22 
human samples and 19 samples from mice were examined. (N = 14 for Pg- and N = 8 for Pg+ for humans and 
N = 10 for Pg- and N = 9 for Pg+ for mice). Mann-Whitney test indicates ****p < 0.0001 for both humans and 
mice. (C) Pearson’s correlation analysis showing a strong correlation between the number of Pg and the number 
of bihormonal cells per field in humans (r = 0.821, ****p < 0.0001). (D) Spearman’s correlation analysis 
indicates a strong correlation between these two variables in mice (r = 0.853, ****p < 0.0001). 8 samples are 
overlapping at zero Pg and zero bihormonal cells (red asterisk).
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Detection of Pg specific 16S rRNA genes by qPCR. Genomic DNA was extracted from formalin 
fixed paraffin embedded (FFPE) mouse pancreatic samples using a MaxwellRSC device and the Maxwell DNA 
FFPE kit (AS1450, Promega Corporation, Madison, WI) and from human frozen pancreatic samples following 
homogenization in TE Buffer pH 8.0 using an MP FatsPrep-24 5 G homogenizer for 30 seconds. Homogenized 
samples were extracted using the Maxwell 16 Tissue DNA Purification Kit based on manufacturer’s instruc-
tions (Promega Corporation, Madison, WI). Primers and probes were synthesized as described by Boutaga et 
al.52. The sequences of the Pg16S rRNA gene forward primers were GCGCTCAACGTTCAGCC, reverse primers 
were CACGAATTCCGCCTGC, and probe was CACTGAACTCAAGCCCGGCAGTTTCAA. PCR primers and 
TaqMan probe for detection of Pg were custom made by Integrated DNA Technologies (IDT, Coralville, IA) 
with a 6-FAM fluorescent label and both Zen internal and 3’ Iowa Black fluorescence quenchers. A synthetic 
double-stranded DNA standard for 16S rRNA gene was synthesized as a gBLOCK fragment (IDT, San Jose, CA)5. 
The standard contained 243 bp of the16S rRNA gene from the Pg strain W83, and greater than 60 bp of adjacent 
DNA on either side of the target sites. The double-stranded gBLOCK oligonucleotide was diluted across 8 orders 
of magnitude, and used as a standard for quantitation of Pg 16S rRNA genes in genomic DNA extracts. The 
concentration of the standards was assessed using Qubit fluorimetry, and the copies per microliter assessed by 
estimation of the DNA weight/molecule based on sequence and sequence length and the DNA concentration. 
Together with a dilution series, absolute quantification (copies per microliter of nucleic acid extract) of samples 
was assessed through linear regression analysis from the standard curve. All assays were performed in technical 
triplicates. PCR amplification was performed in a total reaction mixture volume of 25 μl. The reaction mixtures 
contained 12.5 μl of 2x TaqMan universal PCR master mix (4304437, Thermo Fisher Scientific), 300 nM each 
Pg-specific primer, 100 nM Pg-specific probe, and purified DNA. The samples were subjected to an initial ampli-
fication cycle of 50 °C for 2 min and 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min5.
Statistical analysis. Nonparametric data, Pg 16S copy number in mice and human samples as well as ipGTT, 
glucose, insulin and HOMA-IR, were evaluated by the Mann-Whitney U-test for two-group comparisons. The 
proportion of subjects with Pg+ in pancreas was analyzed between DM and Non-DM groups using a Chi-square 
test. Shapiro-Wilk test was used to determine the distribution of the data. Based on the results of Shapiro-Wilk 
test, the Pearson’s correlation analysis was used to analyze the correlation between the number of bihormonal 
cells and the number of Pg in humans, and Spearman’s correlation analysis was used for mice samples. All other 
statistical analyses were done using a Student’s t-test with a cutoff value of p < 0.05 considered significant.
Data availability
The data sets analyzed for this study are available from the corresponding author upon reasonable request.
Figure 10. Animals with oral application of Pg develop severe glucose intolerance, IR and hyperinsulinemia 
but maintain normal glucose levels. (A) Animals with oral application of Pg (solid line, designated as E) develop 
glucose intolerance compared with control (dotted line, designated as C) by week 22 (N = 10 for each group). 
AUC stands for area under the curve. *p < 0.05, ***p < 0.001. (B) Insulin resistance (HOMA-IR). (C) Fasting 
insulin and (D) glucose levels were determined at week 1 (baseline B) and 22 weeks. Data are shown as mean ± 
S.D. in (B–D). *p < 0.05.
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